11 episodes

Interviews from the 2016 Immuno-Oncology Hong Kong meeting.

Hong Kong Immuno-Oncology 2016 ecancer

    • Medicine

Interviews from the 2016 Immuno-Oncology Hong Kong meeting.

    • video
    Views from the hospital: Medical oncology in Hong Kong

    Views from the hospital: Medical oncology in Hong Kong

    David Johnson meets with ecancertv at Immuno-Oncology Hong Kong 2016 meeting to discuss his experience in training as a medical oncologist.

    • 6 min
    • video
    Combining radiotherapy with immunotherapy

    Combining radiotherapy with immunotherapy

    Dr Welsh speaks with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting about combined radio-immunotherapy.

    He outlines prospective research into using radiation-induced tumour cell death to develop personalised cancer 'vaccines' for patients, and considers the multiple sites of treatment in ongoing trials.

    • 6 min
    • video
    Promising partners for check-point immunotherapy for HCC?

    Promising partners for check-point immunotherapy for HCC?

    Dr Chan speaks with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting about predisposing factors of developing hepatocellular carcinoma, and how they might be tackled before cancer develops.

    He describes how vaccines and anti-viral therapies have limited tumourigenic hepatitis infections, and how screening for alpha-fetoprotein or interleukin 10 can provide actionable biomarkers.

    With regards to immunotherapeutic targets, Dr Chan considers how OX40, VEGF targeting and T cell therapy can improve response in combination with PD-1 checkpoint therapy,

    • 6 min
    • video
    Gastric cancer biology and aetiology

    Gastric cancer biology and aetiology

    Prof Lordick speaks with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting about the classifications of gastric cancer, and how they might inform treatment.

    He outlines known biomarkers for patient subtyping, and considers when sequential treatment, anti-angiogenic therapy or combination therapies might be best used.

    Prof Lordick also introduces the 2019 Gastric Cancer Congress in Prague.

    • 2 min
    • video
    Managing metastatic gastric cancer

    Managing metastatic gastric cancer

    Prof Sakai speaks with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting about the staging of therapies for metastatic gastric cancer.

    He outlines which therapy is suited to first and second line therapy, with ongoing research for immunotherapy and targeted molecules work in combination for these patients.

    • 1 min
    • video
    Immunotherapy for gastric cancer

    Immunotherapy for gastric cancer

    Dr Bang meets with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting to discuss the current status, and future developments, of immunotherapy for treating gastric cancers.

    He considers PD-1 as biomarker for patient selection and guiding treatment, with ongoing clinical trials to determine its utility.

    • 2 min

Top Podcasts In Medicine

More by ecancer